Holland Capital successfully raises a new private equity fund of EUR 225 million after a swift fundraising period
Amsterdam/Düsseldorf, March 5, 2024 – After a fundraising period of five months, Holland Capital has established its new investment fund, Holland Capital Growth & Buy Out Fund V. There was significant interest from both existing and new investors, leading to the fund being oversubscribed. As a result, a first-and-final closing occurred at the hard cap of EUR 225 million. Investors in this new fund include (international) institutional parties, family offices, and entrepreneurs (many of whom are active in Healthcare and Technology). The fund is classified as an Article 8 fund under the Sustainable Finance Disclosure Regulation (SFDR).
The fund will continue its existing strategy
Holland Capital will deploy the capital for investments in medium-sized Dutch and German companies operating in the Healthcare, Technology, and Agrifood-Tech sectors. This aligns the investment strategy of this fund with its previous funds. With the SFDR Article 8 classification and the related ESG objectives of the fund, Holland Capital reaffirms its ambitions in this regard.
The fund manager aims to realize 15 to 20 platform investments in the coming years with the available capital. Holland Capital benefits from a continuous and robust lead flow in the mentioned sectors. The first planned investments are already in the final stages of ‘due diligence.’
As an active shareholder, Holland Capital adds value by providing not only capital but also knowledge, a network, and hands-on support in the professionalization of the organization and realization of buy-and-build strategies. Over the past 40 years, Holland Capital has supported over 180 entrepreneurs in growing their businesses. Ewout Prins and Hubert Verbeek, managing partners at Holland Capital, state, “We very much look forward to collaborating with entrepreneurs in this fund, creating value by supporting their companies to a next phase.”
Margot Engels, operational partner & CEO at Holland Capital, “We are grateful for the trust of our investors. The overwhelming enthusiasm is a testament to confidence in Holland Capital’s distinctive approach.”
About Holland Capital
For over 40 years, Holland Capital has responsibly and successfully invested in promising Dutch and German SMEs with growth ambitions. The team understands entrepreneurship and aims for an open, sustainable, and professional relationship with the management teams of the invested companies, with the shared goal of achieving growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare, Technology, and recently added Agrifood-Tech sectors. The team is familiar with the dynamics and opportunities in these sectors and has an extensive network.
Following this successful fundraising, Holland Capital’s total assets under management amount to EUR 500 million, and it currently holds 38 companies in its portfolio. For the fund manager, this marks the eleventh and largest fund since the organization’s establishment in 1981.
Yenlo and Fides join forces
Amsterdam, 21 September 2020 – Our portfolio company Yenlo (the integration specialist in the field of API and ESB technology) and Fides (the AFAS migration and integration partner for healthcare and education) join forces to support the integration for customers with...
Holland Capital invests in innovative primary care IT platform HealthConnected
Amsterdam/Alkmaar, September 1st, 2020 – Holland Capital, a Dutch based investment firm, invests in HealthConnected, a healthcare IT platform for the primary care market. This investment enables HealthConnected to focus on the expansion to new regions in the...
Holland Capital investeert in innovatief eerstelijns IT-zorgplatform HealthConnected
Amsterdam/Alkmaar, 1 september 2020 - Participatiemaatschappij Holland Capital investeert in HealthConnected, een IT-zorgplatform voor eerstelijnszorg. Met de investering richt HealthConnected zich op de uitrol naar nieuwe regio’s in Nederland en de verdere...
Sirius Medical haalt EUR 4,4 miljoen op om Sirius Pintuition te lanceren
Sirius Medical haalt EUR 4,4 miljoen op om Sirius Pintuition te lancerenEen innovatieve borstkanker lokalisatie technologie Amsterdam, 14 juli 2020 – Participatiemaatschappij Holland Capital investeert samen met BOM Brabant Ventures en Curie Capital 4,4 miljoen euro...
Sirius Medical raises €4.4M to launch Sirius Pintuition
Sirius Medical raises €4.4M to launch Sirius PintuitionAn innovative breast cancer localization technology Amsterdam, July 14th, 2020 – Investment company Holland Capital invests 4.4 million euros in Sirius Medical together with BOM Brabant Ventures and Curie Capital....
Investeren in Coronatijd: Hubert Verbeek aan het woord
Interview met Hubert Verbeek door Jos Schelfhout van Navigator Network Executive Search. Originele bron. Hubert Verbeek: ‘best practices’ helpt de bedrijven in ons portfolio Een rondje langs investeerders. Met hen bespreken we de huidige ‘Corona-tijd’; hoe kijken zij...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl